Global Biosimilars Market Research Report 2023: A $105+ Billion Industry by 2031 - Patent Expiration of Blockbuster Biologic Drugs Driving Rapid Growth
May 31, 2023 09:08 ET
|
Research and Markets
Dublin, May 31, 2023 (GLOBE NEWSWIRE) -- The "Global Biosimilars Market Report and Forecast 2023-2031" report has been added to ResearchAndMarkets.com's offering.The biosimilars market size...
Germany Biosimilars Business and Investment Opportunities to 2027
May 08, 2023 11:28 ET
|
Research and Markets
Dublin, May 08, 2023 (GLOBE NEWSWIRE) -- The "Germany Biosimilars Business and Investment Opportunities Databook - Q1 2023 Update" report has been added to ResearchAndMarkets.com's offering. ...
France Biosimilars Business and Investment Opportunities to 2027
May 08, 2023 10:38 ET
|
Research and Markets
Dublin, May 08, 2023 (GLOBE NEWSWIRE) -- The "France Biosimilars Business and Investment Opportunities Databook - Q1 2023 Update" report has been added to ResearchAndMarkets.com's offering. ...
Brazil Biosimilars Databook 2023: Product, Type of Cell, Imaging Technique, Procedure, Source of Manufacturing, Applications, Type of Technology, and End Users 2018-2027
May 08, 2023 08:23 ET
|
Research and Markets
Dublin, May 08, 2023 (GLOBE NEWSWIRE) -- The "Brazil Biosimilars Business and Investment Opportunities Databook - Q1 2023 Update" report has been added to ResearchAndMarkets.com's offering. ...
Japan Biosimilars Business and Investment Opportunities Report 2023: Market Size is Expected to Record a CAGR of 29.2% During 2023-2027 to Reach US$3,203.6 Million by 2027
May 05, 2023 10:13 ET
|
Research and Markets
Dublin, May 05, 2023 (GLOBE NEWSWIRE) -- The "Japan Biosimilars Business and Investment Opportunities Databook - Q1 2023 Update" report has been added to ResearchAndMarkets.com's offering. ...
South Korea Biosimilars Business and Investment Opportunities Report 2023
May 05, 2023 10:03 ET
|
Research and Markets
Dublin, May 05, 2023 (GLOBE NEWSWIRE) -- The "South Korea Biosimilars Business and Investment Opportunities Databook - Q1 2023 Update" report has been added to ResearchAndMarkets.com's offering. ...
Canada Biosimilars Business and Investment Opportunities Databook, 2018-2022 & 2023-2027
May 05, 2023 09:38 ET
|
Research and Markets
Dublin, May 05, 2023 (GLOBE NEWSWIRE) -- The "Canada Biosimilars Business and Investment Opportunities Databook - Q1 2023 Update" report has been added to ResearchAndMarkets.com's offering. ...
Global Filgrastim Biosimilars Market Research Report 2023: Focus on Zarxio, Nivestym, and Releuko
May 02, 2023 06:03 ET
|
Research and Markets
Dublin, May 02, 2023 (GLOBE NEWSWIRE) -- The "Filgrastim Biosimilars Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.The global filgrastim biosimilars market...
Oral Biologics & Biosimilars Global Market Report 2023: Creation of an Insulin Biosimilar Presents Lucrative Opportunities
April 20, 2023 08:18 ET
|
Research and Markets
Dublin, April 20, 2023 (GLOBE NEWSWIRE) -- The "Oral Biologics & Biosimilars Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.The global oral biologics...
Global Biosimilars Business and Investment Opportunities 2023: Sector to Reach $42.3 Billion by 2026 at a 22% CAGR
April 18, 2023 05:58 ET
|
Research and Markets
Dublin, April 18, 2023 (GLOBE NEWSWIRE) -- The "Global Biosimilars Business and Investment Opportunities - Analysis & Market Size by Technology, Clinical Trials, Patents, Financial Deals,...